A GWAS‑identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma

Su,Tong; Han,Yifang; Yu,Yongwei; Tan,Xiaojie; Li,Xiaopan; Hou,Jianguo; Du,Yan; Shen,Jian; Wang,Guoping; Ma,Liye; Jiang,Shuang; Zhang,Hongwei; Cao,Guangwen

doi:10.3892/ol.2013.1422

A GWAS‑identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma

Authors:
- Tong Su
- Yifang Han
- Yongwei Yu
- Xiaojie Tan
- Xiaopan Li
- Jianguo Hou
- Yan Du
- Jian Shen
- Guoping Wang
- Liye Ma
- Shuang Jiang
- Hongwei Zhang
- Guangwen Cao
View Affiliations

Affiliations: Department of Epidemiology, Second Military Medical University, Shanghai 200433, P.R. China, Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China, Physical Examination Center, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
Published online on: June 25, 2013 https://doi.org/10.3892/ol.2013.1422
Pages: 421-426

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genome‑wide association studies have been used to identify single nucleotide polymorphisms (SNPs) associated with renal cell carcinoma (RCC) in European individuals. The current study aimed to evaluate the correlation between significant SNPs identified in European individuals and the occurrence and postoperative prognosis of RCC in Chinese individuals. A total of 400 cases and 806 controls were involved in the current study. rs4765623, rs7105934, rs7579899 and rs1867785 were genotyped using qPCR, and the expression of cyclin D1 in renal tissue and RCCs was determined via western blotting and immunohistochemistry. The correlation between the SNPs/cyclin D1 expression and overall survival was evaluated using multivariate Cox regression analyses. Of the four SNPs, only rs7105934 was found to significantly correlate with RCC risk in Chinese individuals. The rs7105934 GA + AA genotype was correlated with a reduced risk of RCC with an odds ratio of 0.64 (95% confidence interval [CI], 0.43‑0.96), following adjustment for age. This genotype was found to independently predict an improved postoperative prognosis in the multivariate analysis, with a hazard ratio (HR) of 0.12 (95% CI, 0.02‑0.93). Expression of cyclin D1, a putative regulated protein of rs7105934, did not vary in adjacent renal tissue and tumors when compared with that of various rs7105934 genotypes. However, cyclin D1 expression in RCCs inversely correlated with advanced tumor stage, and moderate to high expression of cyclin D1 in RCCs independently predicted improved postoperative prognosis, with an HR of 0.13 (95% CI, 0.02‑0.96). Observations of the present study indicate that the rs7105934 A allele is associated with reduced risk and improved postoperative prognosis of RCC; however, this effect is unlikely to be caused by cyclin D1 expression.

View Figures

View References

1.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Chow WH, Dong LM and Devesa SS: Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
3.	Southard EB, Roff A, Fortugno T, et al: Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol Biomarkers Prev. 21:191–201. 2012. View Article : Google Scholar : PubMed/NCBI
4.	Wang G, Hou J, Ma L, et al: Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol. 36:177–182. 2012. View Article : Google Scholar : PubMed/NCBI
5.	Moore LE, Brennan P, Karami S, et al: Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis. 28:1960–1964. 2007. View Article : Google Scholar
6.	Moore LE, Boffetta P, Karami S, et al: Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res. 70:6527–6536. 2010. View Article : Google Scholar
7.	Bruyère F, Hovens CM, Marson MN, et al: VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol. 184:1273–1278. 2010.PubMed/NCBI
8.	Hirata H, Hinoda Y, Nakajima K, et al: Wnt antagonist gene polymorphisms and renal cancer. Cancer. 115:4488–4503. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Andreotti G, Boffetta P, Rosenberg PS, et al: Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis. 31:614–620. 2010. View Article : Google Scholar : PubMed/NCBI
10.	Longuemaux S, Deloménie C, Gallou C, et al: Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res. 59:2903–2908. 1999.
11.	Aben KK, Luth TK, Janssen-Heijnen ML, Mulders PF, Kiemeney LA and van Spronsen DJ: No improvement in renal cell carcinoma survival: a population-based study in the Netherlands. Eur J Cancer. 44:1701–1709. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Sun M, Shariat SF, Cheng C, et al: Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 60:644–661. 2011. View Article : Google Scholar : PubMed/NCBI
13.	Lughezzani G, Karakiewicz PI, Bigot P, et al: The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma. Eur J Cancer. 46:1927–1935. 2010. View Article : Google Scholar : PubMed/NCBI
14.	Doberstein K, Wieland A, Lee SB, et al: L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis. 32:262–270. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Kojima T, Shimazui T, Horie R, et al: FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma. Genes Chromosomes Cancer. 49:379–389. 2010.PubMed/NCBI
16.	Li X, Tan X, Yu Y, et al: D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta. Cancer. 117:4201–4211. 2011. View Article : Google Scholar
17.	Kleinrath T, Gassner C, Lackner P, Thurnher M and Ramoner R: Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. J Clin Oncol. 25:845–851. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Hirata H, Hinoda Y, Kikuno N, et al: MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res. 13:4123–4129. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG and Wu X: Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 31:1805–1812. 2010. View Article : Google Scholar : PubMed/NCBI
20.	Purdue MP, Johansson M, Zelenika D, et al: Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 43:60–65. 2011. View Article : Google Scholar : PubMed/NCBI
21.	Schödel J, Bardella C, Sciesielski LK, et al: Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat Genet. 44:420–425. 2012.PubMed/NCBI
22.	Chang W, Ma L, Lin L, et al: Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer. 125:2844–2853. 2009. View Article : Google Scholar : PubMed/NCBI
23.	Wu X, Scelo G, Purdue MP, et al: A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet. 21:456–462. 2012. View Article : Google Scholar : PubMed/NCBI
24.	Han SS, Yeager M, Moore LE, et al: The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet. 21:1190–1200. 2012. View Article : Google Scholar : PubMed/NCBI
25.	Cao Q, Qin C, Ju X, et al: Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population. Mutagenesis. 27:345–350. 2012. View Article : Google Scholar : PubMed/NCBI
26.	Hedberg Y, Davoodi E, Roos G, Ljungberg B and Landberg G: Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer. 84:268–272. 1999. View Article : Google Scholar : PubMed/NCBI
27.	Phuoc NB, Ehara H, Gotoh T, et al: Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Urology. 69:843–848. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res. 11:1190–1197. 2005.PubMed/NCBI
29.	Migita T, Oda Y, Naito S and Tsuneyoshi M: Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer. 94:973–979. 2002. View Article : Google Scholar : PubMed/NCBI
30.	Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K and Tomita Y: Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Clin Cancer Res. 6:460–466. 2000.PubMed/NCBI